Cargando…

Role of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Systematic Review and Updated Meta-Analysis of Risk Markers for Sudden Death

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is associated with sudden death (SD). Myocardial fibrosis is reportedly correlated with SD. OBJECTIVE: We performed a systematic review with meta-analysis, updating the risk markers (RMs) in HCM emphasizing myocardial fibrosis. METHODS: We reviewed HCM s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bittencourt, Marcelo Imbroinise, Cader, Samária Ali, Araújo, Denizar Vianna, Salles, Ana Luiza Ferreira, de Albuquerque, Felipe Neves, Spineti, Pedro Pimenta de Mello, de Albuquerque, Denilson Campos, Mourilhe-Rocha, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6424049/ https://www.ncbi.nlm.nih.gov/pubmed/30916191 http://dx.doi.org/10.5935/abc.20190045

Ejemplares similares

O Polimorfismo Genético do Receptor Beta-Adrenérgico Tipo 1 Ser49Gly é Preditor de Morte em Pacientes Brasileiros com Insuficiência Cardíaca
por: de Albuquerque, Felipe Neves, et al.
Publicado: (2020)

Segurança dos Procedimentos da Cardiologia Intervencionista na Síndrome Coronariana Crônica durante a Pandemia de COVID-19
por: Ferreira, Esmeralci, et al.
Publicado: (2020)

Angiotensin-converting enzyme genetic polymorphism: its impact on cardiac remodeling
por: de Albuquerque, Felipe Neves, et al.
Publicado: (2014)

Description of a New GLA Gene Variant in a Patient with Hypertrophic Cardiomyopathy. Is it Fabry Disease?
por: Bittencourt, Marcelo Imbroinise
Publicado: (2019)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018)

Influence of Angiotensin-Converting-Enzyme Gene Polymorphism on Echocardiographic Data of Patients with Ischemic Heart Failure
por: Duque, Gustavo Salgado, et al.
Publicado: (2016)

Custo-efetividade do Stent Farmacológico na Intervenção Coronariana Percutânea no SUS
por: Pessoa, João Addison, et al.
Publicado: (2020)

Evaluating Sodium Restriction in Heart Failure
por: Spineti, Pedro Pimenta de Mello
Publicado: (2019)

Biomarkers in Heart Failure
por: Spineti, Pedro Pimenta de Mello
Publicado: (2019)

Qual o Papel dos Biomarcadores de Lesão Renal na Nefropatia Induzida por Contraste?
por: Spineti, Pedro Pimenta de Mello
Publicado: (2021)

Síndrome Cardiorrenal Aguda: Qual Critério Diagnóstico Utilizar e sua Importância para o Prognóstico?
por: Leite, Andréa de Melo, et al.
Publicado: (2020)

Clinical Outcomes and Cost-Effectiveness Analysis of FFR Compared with Angiography in Multivessel Disease Patient
por: Quintella, Edgard Freitas, et al.
Publicado: (2019)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

Defying the Odds of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
por: Rostomian, Ara H., et al.
Publicado: (2020)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

Strain Analysis of Left Ventricular Function in the Association of Hypertrophic Cardiomyopathy and Systemic Arterial Hypertension
por: Gil, Thereza Cristina Pereira, et al.
Publicado: (2019)

Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy
por: Östman-Smith, Ingegerd, et al.
Publicado: (2010)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy
por: Montenegro Camanho, Luiz Eduardo, et al.
Publicado: (2019)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?
por: Reis, Liliana, et al.
Publicado: (2018)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Shen, Hua, et al.
Publicado: (2022)

Correlation of Electrocardiographic Changes with Cardiac Magnetic Resonance Findings in Patients with Hypertrophic Cardiomyopathy
por: Paixão, Gabriela Miana de Mattos, et al.
Publicado: (2018)

Hypertrophic Cardiomyopathy Mimicking Acute Anterior Myocardial Infarction Associated with Sudden Cardiac Death
por: Daralammouri, Y., et al.
Publicado: (2012)

Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score
por: Östman-Smith, Ingegerd, et al.
Publicado: (2017)

A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy
por: Miron, Anastasia, et al.
Publicado: (2020)

Novel FHL1 Mutation Associated With Hypertrophic Cardiomyopathy, Sudden Cardiac Death, and Myopathy
por: Binder, M. Scott, et al.
Publicado: (2020)

Ventricular fibrillation and sudden cardiac arrest in apical hypertrophic cardiomyopathy: Two case reports
por: Park, Yae Min, et al.
Publicado: (2021)

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?
por: Östman-Smith, Ingegerd
Publicado: (2022)

Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death
por: Chiribiri, A., et al.
Publicado: (2015)

Refractory secondary hyperparathyroidism in waiting list for parathyroidectomy: who we should operate first in a quaternary hospital in Brazil regarding survival
por: Assumpção, Lia Roque, et al.
Publicado: (2019)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

Ehlers-Danlos Syndrome associated with cardiomyopathy hypertrophic obstructive
por: Pinto, Raimundo José Almeida de Oliveira, et al.
Publicado: (2015)

Left Atrial Septal Pouch and Acute Thromboembolic Ischemia of the Upper Limb
por: Ferreira, Esmeralci, et al.
Publicado: (2021)

High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy
por: Gommans, D. H. Frank, et al.
Publicado: (2017)

Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging
por: Śpiewak, Mateusz, et al.
Publicado: (2021)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance
por: Stankowski, Kamil, et al.
Publicado: (2023)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ihpl09oqlfodlp1mqirb899vrf